Search hospitals > Quebec > MONTREAL
Hopital du Sacre Coeur de Montreal
Claim this profileMONTREAL, Quebec H4J 1C5
Global Leader in Breast Cancer
Conducts research for Asthma
Conducts research for Coronary Artery Disease
Conducts research for Lymphoma
Conducts research for Allergy and Asthma
128 reported clinical trials
7 medical researchers
Summary
Hopital du Sacre Coeur de Montreal is a medical facility located in MONTREAL, Quebec. This center is recognized for care of Breast Cancer, Asthma, Coronary Artery Disease, Lymphoma, Allergy and Asthma and other specialties. Hopital du Sacre Coeur de Montreal is involved with conducting 128 clinical trials across 198 conditions. There are 7 research doctors associated with this hospital, such as Remi Goupil, MD MSc, Setareh Samimi, Kevin Jao, and Isabelle Gingras.Area of expertise
1Breast Cancer
Global LeaderStage I
HER2 negative
Stage II
2Asthma
Top PIs
Remi Goupil, MD MScHôpital du Sacré-Coeur de Montréal4 years of reported clinical research
Studies Chronic Kidney Disease
Studies Contrast-induced Nephropathy
3 reported clinical trials
3 drugs studied
Setareh SamimiHopital Du Sacre-Coeur de Montreal5 years of reported clinical research
Studies Colon Cancer
2 reported clinical trials
9 drugs studied
Kevin JaoHopital Du Sacre Coeur de Montreal5 years of reported clinical research
Studies Non-Small Cell Lung Cancer
Studies Lung Cancer
1 reported clinical trial
4 drugs studied
Isabelle GingrasCentre intégré universitaire de santé et de services sociaux du Nord-de-l'Île-de-Montréal (CIUSSS NÎM) - Hôpital du Sacré-Coeur de Montréal2 years of reported clinical research
Studies Breast Cancer
1 reported clinical trial
5 drugs studied
Clinical Trials running at Hopital du Sacre Coeur de Montreal
Spinal Cord Injury
Atrial Fibrillation
Crohn's Disease
Breast Cancer
Colon Cancer
Cardiovascular Disease
Stroke
Hemorrhage
Conn's syndrome
Trace Element Excess
SCPP Management
for Spinal Cord Injury
This multicenter study will enroll 100 patients with acute traumatic cervical and thoracic SCI who have a lumbar intrathecal catheter inserted within 24 hours of their injury. The lumbar intrathecal catheter will be inserted pre-operatively for the measurement of ITP and the collection of cerebrospinal fluid (CSF) samples. SCPP will be calculated as the difference between MAP and the ITP. There are two important distinct yet related objectives in this prospective interventional study. 1. Determine the effect of SCPP maintenance ≥ 65 mmHg in acute SCI on neurologic recovery as measured by ASIA Impairment Scale (AIS) grade conversion and motor score improvement. 2. Collect CSF and blood samples for the measurement of neurochemical biomarkers and storage for future biomarker discovery and validation studies.
Recruiting1 award N/A6 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Hopital du Sacre Coeur de Montreal?
Hopital du Sacre Coeur de Montreal is a medical facility located in MONTREAL, Quebec. This center is recognized for care of Breast Cancer, Asthma, Coronary Artery Disease, Lymphoma, Allergy and Asthma and other specialties. Hopital du Sacre Coeur de Montreal is involved with conducting 128 clinical trials across 198 conditions. There are 7 research doctors associated with this hospital, such as Remi Goupil, MD MSc, Setareh Samimi, Kevin Jao, and Isabelle Gingras.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.